Hiv Vaccine Trials Network (hvtn) - Infectious Diseases

Relevant Publications

Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial.

Issue Release: 2024

Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials.

Issue Release: 2024

The role of randomization inference in unraveling individual treatment effects in early phase vaccine trials.

Issue Release: 2024

Pre-HIV α4β7hi CD4+ T cells and HIV risk among heterosexual individuals in Africa.

Issue Release: 2024

Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial.

Issue Release: 2024

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.

Issue Release: 2023

Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.

Issue Release: 2022

Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa.

Issue Release: 2022

Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responses.

Issue Release: 2022

Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens.

Issue Release: 2022

Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines.

Issue Release: 2022

A qualitative study of stakeholder and researcher perspectives of community engagement practices for HIV vaccine clinical trials in South Africa.

Issue Release: 2022

Establishing communication challenges and preferences among clinical trial participants in an under-resourced setting to improve adherence to study visits and participant retention.

Issue Release: 2021

A retrospective analysis of incident pregnancy in phase 1 and 2a HIV-1 vaccine study participants does not support concern for adverse pregnancy or birth outcomes.

Issue Release: 2021

Meeting report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017.

Issue Release: 2021

Research productivity and collaboration of the NIH-funded HIV vaccine trials network: A bibliometric analysis.

Issue Release: 2021

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.

Issue Release: 2020

Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials.

Issue Release: 2020

Social Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials.

Issue Release: 2020

A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa.

Issue Release: 2020

What are the Clinical Implications of the Inflammatory Response?

What are the Challenges in Controlling Dengue Hemorrhagic Fever?

What is Dexamethasone?

How Are Fungal Infections Treated?

What Role Do Viruses Play in Infectious Diseases?

What is a Virus?

What are Masks and Their Types?

What is the Role of the FDA in Infectious Diseases?

What is the World Health Organization (WHO)?

What Role Does Genomic Structure Play in Antimicrobial Resistance?

Hiv Vaccine Trials Network (hvtn) - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics